Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 122c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($1.83), $1.22 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Sandisk (SNDK) call put ratio 1.8 calls to 1 put with a focus on October 2 weekly calls
• Hyperliquid Strategies (PURR) September 25 weekly 15 and October 14 calls active, share price down 8.2%